معرفی
Matthew Challis is a Research Fellow in the Department of Biochemistry & Molecular Biology at Monash University. His work focuses on antimalarial drug discovery, proteomics, and metabolic signaling pathways. Key collaborations involve institutions like Monash Biomedicine Discovery Institute and international partners in malaria research. His research contributes to Sustainable Development Goals targeting global health challenges.
Expertise includes chemoproteomics for drug target validation, phosphoproteomics analysis of metabolic pathways, and development of novel antiparasitic agents. Recent studies validate enzyme inhibitors against Plasmodium species and identify new therapeutic targets through multi-omics approaches.
Publications highlight cross-species efficacy of dual aminopeptidase inhibitors and SEC22B's role in glucagon signaling. His work bridges chemical biology with clinical applications, emphasizing translational research in infectious diseases.
